Marcel Klaassen
Marcel Klaassen is a Deakin Distinguished Professor and contributor to The Conversation who writes about avian influenza and wildlife disease within the masthead’s health coverage. His work stands out for tying front-line research on bird migration and virus ecology to clear public explainers on Australia’s evolving H5N1 bird flu situation. He approaches bird flu as a problem of animal health, ecology and biosecurity as much as human risk, grounding his pieces in data from wild bird surveillance and his own research on high pathogenicity avian influenza.
Avian influenza and Australia’s first H5N1 cases
Klaassen’s recent coverage at The Conversation focuses on the arrival of H5N1 bird flu in Australia and what it means for wildlife, livestock and people. In his explainer on the first confirmed case of H5N1 in Australia, he walks readers through how a suspected case of deadly H5 bird flu, also known as high pathogenicity avian influenza H5N1, was confirmed in a brown skua. He sets out the biological and epidemiological context of that detection, explaining that the presence of HPAI H5N1 in a wild seabird does not automatically mean the virus will establish itself and spread across the continent into other birds and mammals, including livestock.
His coverage gives practical weight to surveillance and response, stressing that vigilance is essential and advising that people should not touch or take sick animals into their care but instead report suspected cases immediately to the Emergency Animal Disease Hotline. Rather than focusing on headline anxiety, he emphasises how authorities and researchers track cases in wild birds and what specific behaviours the public should follow to limit risk. This framing reflects his broader focus on health as a shared space between wildlife and humans, where biosecurity practices and informed public behaviour are central.
Disease ecology of migratory birds
Klaassen’s journalism is informed by a long research career on the ecology of migratory birds and the way they move pathogens across continents. He leads work that has tested whether high pathogenicity avian influenza H5N1 lineage 2.3.4.4b has entered Australia, finding no evidence for an incursion in 2022 despite global spread of that strain. He also co-authors studies showing that long-distance avian migrants failed to bring lineage 2.3.4.4b HPAI H5N1 into Australia, directly connecting migration routes and infection status to the continent’s disease risk.
His research on predicting HPAI H5N1 susceptibility across species, using ecological and phylogenetic patterns to understand which birds are most at risk, feeds into how he frames bird flu in public writing. He treats migratory seabirds and other wild birds as key actors in an animal pandemic that has affected more than 400 wild bird and 40 mammal species globally since 2021, underscoring that wildlife health is integral to understanding the scale of H5N1. This background allows him to explain, in plain language, why particular species such as skuas and giant petrels are closely watched in Australian surveillance and how their feeding and migratory behaviour shapes exposure to the virus.
Across his work, Klaassen draws on broad research interests that span theoretical, experimental and observational studies of numerous animal, plant and microbe taxa. That breadth shows up when he writes about bird flu as part of wider ecological systems, not as an isolated virological event, describing how habitat, landscape and movement patterns interact with disease circulation.
Research-led health explainers on bird flu
Klaassen’s Conversation pieces read as research-led health explainers: they translate complex, technical findings from scientific studies into direct guidance about risk, surveillance and response. He brings terminology such as “high pathogenicity avian influenza,” lineage designations like 2.3.4.4b, and distinctions between wildlife and poultry outbreaks into accessible prose without losing precision. His writing balances reassurance and caution, stressing that detected cases in wild birds need careful monitoring while avoiding overstating the threat in the absence of evidence for widespread establishment.
He consistently connects national biosecurity questions to concrete actions on the ground, such as enhanced surveillance along southern coasts and targeted monitoring of migratory seabirds that have tested positive for lethal strains overseas. When outlets and institutions seek expert insight on Australia’s H5N1 preparedness, his comments focus on how surveillance programs, ecological knowledge and laboratory testing combine to detect and track incursions. This makes his coverage distinct from general health reporting that centres on clinical cases or human-to-human transmission, because he builds the story from wildlife health and ecosystem dynamics outward.
Given his dual role as a senior academic and journalist at The Conversation, Klaassen occupies a niche where peer-reviewed findings rapidly inform public-facing health coverage. For stories touching on bird flu, wildlife disease, migratory birds or the biosecurity implications of emerging infections, his work offers a perspective rooted in long-term ecological research and current surveillance data.
4 more health journalists.
Abida Tasnim
Abida Tasnim is a health writer for The Daily Star who focuses on clear, practical guidance that helps readers recognise risks early and act before everyday illnesses turn into wider public health problems. She reports on infectious disease prevention, using measles coverage to show how outbreaks start with individual decisions and behaviours, not just hospital statistics. Her work explains what happens during an outbreak and then anchors the story in simple steps people can take, such as avoiding crowded places when symptoms appear, practising good hygiene, and seeking medical advice early. She writes direct, action‑oriented health explainers that turn clinical questions about contagion and disease burden into everyday choices. Across her beat, she stresses early recognition, timely care, and prevention as the foundations of healthier communities.
Adrián Carballo Casla
Adrián Carballo Casla stands out for turning complex cohort data on ageing into clear, food‑level advice on what older adults should eat to protect brain health and slow chronic disease. He is a researcher in nutritional epidemiology focused on ageing and chronic disease prevention and a postdoctoral researcher in geriatric epidemiology at Karolinska Institutet, writing health explainers for The Conversation. He reports on how diet quality, especially Mediterranean and Mind‑style patterns, shapes dementia risk, grey matter loss and neurocognitive ageing, and how healthy versus pro‑inflammatory diets alter multimorbidity trajectories. His articles translate findings on flavonoids, polyphenols, folate, omega‑3 fats and dietary nitrates into specific food choices and small, practical changes. Much of his coverage is anchored in his own studies on multimorbidity, high‑risk older adults and tailored dietary recommendations, often syndicated to other outlets.
Ahmed Elbediwy
Ahmed Elbediwy brings a lab-based understanding of cancer biology and clinical biochemistry to public-facing health reporting, linking drug mechanisms and molecular pathways to everyday choices about medicines and products. He writes for The Conversation on weight-loss injections, cancer overdiagnosis and anti-ageing supplements, focusing on obesity medicine, cancer signalling, screening trade-offs, skincare and supplement science. His pieces on GLP-1 drugs such as Ozempic, Wegovy and Mounjaro explain why some people do not respond, how gut hormones and appetite signals work, and where psychological support and nutrition fit alongside prescriptions. He co-authors explainers on cancer risk and overdiagnosis and on whether supplements can reverse ageing, separating established knowledge from emerging research. An award-winning senior lecturer at Kingston University, he favours clear, structured explainers, careful definition of key terms and evidence-based appraisal over hype.
Amanda Sheppeard
Amanda Sheppeard is a managing editor and health journalist known for long, detailed explainers that connect complex clinical research, disability policy and political narratives with the daily realities of doctors and patients. She works at The Medical Republic across editorial leadership and commercial content while reporting widely on medicine for its specialist titles. Her real beat spans autism, disability policy, autoimmune disease, infectious threats and system pressures in primary care and hospitals. She covers subjects such as autism diagnosis and the NDIS, rheumatology’s clinical shifts, weight-loss agents in rheumatoid arthritis, infection control, antimicrobial resistance and new modalities like CAR T-cell therapy and microneedles. She reports by doing the synthesis inside the story, linking trial design, molecular targets, funding rules and policy changes to concrete decisions and workflows in clinics and hospitals.